摘要
目的:探讨血清AFP、CEA、CA19-9、CA125、TSGF联检对卵巢癌的诊断价值。方法:卵巢病变患者共109例(卵巢癌45例,卵巢良性病变64例),采用分光光度法测定TSGF,采用全自动化学发光法测定AFP、CEA、CA19-9和CA125。结果:卵巢癌组单项阳性率依次为:TSGF 73.33%(33/45)、CA125 60.00%(27/45)、CA19-9 35.56%(16/45)、CEA8.89%(4/45)、AFP 2.22%(1/45)。去除AFP、CEA后,CA19-9、CA125、TSGF三项联检阳性率为91.11(41/45)。结论:CA19-9、CA125、TSGF联检有助于提高卵巢癌的检出率。
Objective To study the diagnostic value of combined detection of serum AFP,CEA,CA19-9,CA125,TSGF levels in patients with ovarian cancer.Methods Spectrophotometry was used to detect serum TSGF levels while automated chemiluminescence was used to determinate serum AFP,CEA,CA19-9,CA125 levels in 109 patients with ovarian diseases（including 45 cases of ovarian cancer,64 cases of ovarian benign disease）.Results The positive rate of single marker in ovarian cancer group was： TSGF 73.33%（33/45）,CA125 60.00%（27/45）,CA19-9 35.56%（16/45）,CEA 8.89%（4/45）,AFP 2.22%（1/45）,respectively.With combined CA19-9,CA125 and TSGF,the positive rate was 91.11（41/45）.Conclusion Combined detecting of CA19-9,CA125,TSGF is helpful for diagnosis of ovarian cancer.
出处
《放射免疫学杂志》
CAS
2009年第4期390-391,共2页
Journal of Radioimmanology
